Hostname: page-component-8448b6f56d-xtgtn Total loading time: 0 Render date: 2024-04-23T17:10:26.374Z Has data issue: false hasContentIssue false

Invasive pneumococcal infection in South and West England

Published online by Cambridge University Press:  01 March 1998

M. D. SMITH
Affiliation:
Public Health Laboratory, Taunton and Somerset Hospital, Musgrove Park, Taunton, TA1 5DB, UK
J. STUART
Affiliation:
Communicable Disease Surveillance Centre (South & West), Public Health Laboratory, Gloucestershire Royal Hospital, Great Western Road, Gloucester, GL1 3NN, UK
N. J. ANDREWS
Affiliation:
PHLS Statistics Unit, Communicable Disease Surveillance Centre, 61 Colindale Avenue, London, NW9 5EQ, UK
W. A. TELFER BRUNTON
Affiliation:
Public Health Laboratory, Penventinnie Lane, Treliske, Truro, TR1 3LQ, UK
K. A. V. CARTWRIGHT
Affiliation:
Public Health Laboratory, Gloucestershire Royal Hospital, Great Western Road, Gloucester, GL1 3NN, UK
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Variation in the incidence of invasive pneumococcal disease across South and West England, in 1995, was measured through a survey of microbiology laboratories. A 100% response rate was achieved. The incidence by laboratory varied between 5·2 and 20·4 per 100000 catchment population (P<0·001). Adjusting for pneumococcal vaccine uptake rate in over 65 year olds, hospital admission rates, blood culture system used and for the age and sex structure of the population, did not account for this variation. When blood culture sampling rates were included in a logistic regression model, the variation between laboratories was much less and of lower statistical significance (P=0·019). Higher rates of blood culture sampling were associated with a higher incidence of invasive pneumococcal disease. Consistently high sampling should be encouraged because a higher diagnostic rate should result in more selective prescribing of antibiotics, and secondly because improved ascertainment of severe pneumococcal infections is a prerequisite for the evaluation of new pneumococcal conjugate vaccines.

Type
Research Article
Copyright
1998 Cambridge University Press